According to a recent LinkedIn post from Entrepreneurs First, portfolio company SquareMind has raised $18 million in funding led by Deeptech 2030 and Sonder Capital. The post notes that SquareMind was co-founded by Ali and Tanguy and has developed an imaging robot designed to scan the entire skin surface within minutes, digitize and map it, and apply AI software to detect anomalies.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post suggests that SquareMind aims to make high-quality skin exams more efficient and accessible by saving dermatologists time and improving diagnostic accuracy, particularly in the early detection of skin cancer where weeks or months can be critical. For investors, this funding round highlights continuing capital flows into AI-enabled medical diagnostics and reinforces Entrepreneurs First’s positioning in deeptech healthcare, potentially enhancing the value of its portfolio if SquareMind’s technology sees strong clinical adoption.
As described in the post, the technology focus on full-body imaging and automated analysis could create a scalable service model for clinics, which may support recurring revenue opportunities if integrated into standard dermatology workflows. The involvement of specialized investors such as Deeptech 2030 and Sonder Capital also indicates external validation of SquareMind’s technical and commercial prospects, which may positively influence Entrepreneurs First’s track record in attracting follow-on capital to its early-stage bets.